期刊文献+

小金缓释微丸的制备及其体外释放度考察 被引量:4

Preparation and Release Test in vitro of Xiaojin Sustained Release Pellets
原文传递
导出
摘要 目的:制备小金缓释微丸,并以阿魏酸为指标,考察不同包衣条件下小金缓释微丸的体外释放度。方法:采用单因素试验优选包衣工艺。结果:以乙基纤维素为包衣材料,包衣增重10%,致孔剂乳糖的用量为12%,可满足10 h缓释的要求。结论:包衣材料、包衣增重以及致孔剂的用量是影响药物释放的关键因素。 Objective:To prepare Xiaojin sustained release pellets and investigate release in vitro of Xiaojin sustained release pellets with different coating conditions by ferulic acid was determined as index.Method:Single factor test was applied to optimize the coating formulations.Result:A 10 h-sustained release curve was satisfactorily obtained by using EC as coating material and lactose 12% as porogenic agent in the optimized coating formulation with a 10% of coating weight gained.Conclusion:Coating material,coating weight gained and the amount of porogenic agent are the key factors that can significantly affect the drug release in vitro.
出处 《中国实验方剂学杂志》 CAS 北大核心 2011年第18期22-25,共4页 Chinese Journal of Experimental Traditional Medical Formulae
基金 国家重大新药创制(2009zx09310-005)
关键词 小金缓释微丸 流化床包衣 体外释放度 Xiaojin sustained release pellets fluidized bed coating release in vitro
  • 相关文献

参考文献4

二级参考文献26

  • 1秦树光,孔繁荣,杨宝良.小金丸联合甲状腺素片治疗甲状腺肿的临床分析[J].现代中西医结合杂志,2005,14(8):1018-1018. 被引量:7
  • 2杨玉国,刘加升.小金丸与三苯氧胺合用治疗乳腺囊性增生病250例分析[J].实用中医药杂志,2005,21(5):261-261. 被引量:14
  • 3吴亚旭.中药治疗结节性筋膜炎5例[J].江苏中医药,2005,26(11):27-28. 被引量:1
  • 4余勇.小金丸治疗聚合性痤疮24例[J].医药导报,2000,19(3):263-263.
  • 5Mehta KA, Kislalioglu MS, Phuapradit W, et al. Release performance of a poorly soluble drug from a novel, Eudragit(R)based multi-unit erosion matrix [ J ]. Int J Pharm,2001, 213(1/2):7- 12.
  • 6Pillay V, Fassihi R. In vitro release modulation from crosslinked pellets for site-specific drug delivery to the gastrointestinal tract. Ⅰ . Comparison of pH-responsive dmg release and associated kinetics[J]. J Control Release, 1999,59(2) :229 - 242.
  • 7Santos H, Veiga F, Pina M, et al. Physical properties of chitosan pellets produced by extrusion-spheronisation: influence of formulation variables[J]. Int J Pharm, 2002, 246(1/2): 153 - 169.
  • 8Alvarez L, Concheiro A, Gomez-Amoza JL, et al. Powdered cellulose as excipient for extrusion-spheronization pellets of a cohesive hydrophobic drug[J]. Eur J Pharm Biopharm, 20O3, 55(3) :291 - 295.
  • 9Tho I, Snade SA, Kleinebudde P. Disintegrating pellets from a water-insoluble pectin derivative produced by extruion/spheronisation[J]. Eur J Pharm Biopharm, 2003,56(3) :371 - 380.
  • 10Vergote GJ, Vervaet C, Van Driessche I, et al. An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen [ J]. Int J Pharm, 2001, 219(1/2): 81 - 87.

共引文献1012

同被引文献60

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部